Lloyd S. Miller, MD, PhD, writes about understanding the overlapping immune pathways between psoriasis and psoriatic arthritis that may be useful to develop treatment plans for patients with these conditions.
John Botson, MD, provides his perspective on including immunodulatory therapy in combination with pegloticase and encourages clinicians to evolve their standard of care in the treatment of uncontrolled gout.
Jim Anderson, MPAS, PA-C, explores COVID-19 fatigue and how it is all a bit numbing for medical providers who are trying to do their best to treat patients while clinging to trusted sources to help guide the way.
Ben Nowell, PhD, and Shilpa Venkatachalam, PhD, provide an overview of the evolution of telemedicine during the COVID-19 pandemic and the associated barriers among patients with autoimmune rheumatic diseases.
In recognition of American Heart Month 2022, Jasvinder Singh, MD, evaluates the association between gout and cardiac disease, based on published literature.
Nicole Bundy, MD, discusses the ways in which health care professionals, including rheumatologists, can create meaningful relationships and have open communication with their patients with long-haul COVID.
Nicole Bundy, MD, MPH, discusses the need for lifestyle interventions, in addition to pharmacologic treatment, during the management of patients with autoimmune diseases.
Michael C. Schweitz, MD, discusses how a South Florida arthritis clinic, which provides care to vulnerable patients with rheumatologic conditions, was saved from closing with the help of CreakyJoints.
In this perspective, S. Louis Bridges Jr, MD, PhD, provides insight into managing care for patients with rheumatic diseases during the COVID-19 pandemic.
